Phung Osborn
Vice President and Head of Global Market Access, Cell Therapy, Bristol Myers Squibb
Phung Osborn is listed as Vice President and Head of Global Market Access, Cell Therapy, Bristol Myers Squibb. Phung is scheduled to speak at Advanced Therapies Week 2027 on 19 January 2027.
Compiled from published conference agendas; not yet confirmed by Phung. Is this you? Claim this profile.
About
As the VP, Head of Global Market Access, Cell Therapy at BMS, Phung brings over 30 years of experience in building market access and payer teams through strategic positioning and customer-focused solutions. Her career has been dedicated to bringing innovative medications to market, spanning from autoimmune to hematologic disorders. Phung has been a leader across the U.S. healthcare system, adeptly navigating access to care and medication for rare diseases. Her diverse experience spans across companies such as JNJ, Baxter, Iovance, Orca Bio, and Prime Therapeutics.
Upcoming
Advanced Therapies Week 2027 19 January 2027 – 21 January 2027
- Keynote industry perspective Speaker · 19 January 2027
- Plenary: How must healthcare and industry models evolve to achieve the elusive goal of improved patient access? Speaker · 19 January 2027
Spoke alongside
People who have shared a session with Phung at events on B2DB.
- George Eastwood Executive Director · Emily Whitehead Foundation 1 shared session
- Peter Marks Senior Vice President of Molecule Discovery & Head of Infectious Disease · Eli Lilly and Company 1 shared session
- Scott Gottlieb Partner · New Enterprise Associates 1 shared session
- Susan Nichols Chief Executive Officer · Propel Biosciences 1 shared session